5PQ79_:ZYXW&>GITRZ|Q
SYSTEM PROCESSING...
5PQ79_:ZYXW&>GITRZ|Q
SYSTEM PROCESSING...
Posted: 2025-05-15 12:20:37 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-15 12:21:24 UTC
Verified By
Rollup News
A novel Copper(II) dipyridohenazine complex demonstrates synergistic cuproptosis/chemodynamic anticancer therapy for triple negative breast cancer, validated by in vivo studies on mice.
Novel Copper(II) complex for anticancer therapy
Synergistic cuproptosis/chemodynamic action
Effective treatment for triple negative breast cancer
In vivo validation of antitumor efficacy
Treating challenging triple negative breast cancer